Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present Eight Studies at the 2018 American Society of Clinical Oncology Annual Meeting

SALT LAKE CITY, May 15, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will present results from...
May 08, 2018 06:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results

Total Revenues of $193.5 Million GAAP Diluted EPS of $0.16 and Adjusted EPS of $0.31 Up 15 PercentCompany Raises Both Revenue and Adjusted EPS Guidance for Fiscal Year 2018Company Announces Commercial...
May 07, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Landmark Study Shows GeneSight® Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder

SALT LAKE CITY, May 07, 2018 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that results from a large, well-controlled...
May 04, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer

SALT LAKE CITY, May 04, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will present results from...
May 02, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Named to Forbes 2018 List of America’s Best Midsize Employers

SALT LAKE CITY, May 02, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that the company was named to...
April 27, 2018 07:10 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at Two Upcoming Healthcare Conferences

SALT LAKE CITY, April 27, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president...
April 27, 2018 07:05 ET | Source: Myriad Genetics, Inc.

New Study Finds that 24 Percent of Women Seen in the Obstetrics-Gynecology Setting Met NCCN Guidelines for Hereditary Cancer Genetic Testing

SALT LAKE CITY, April 27, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that results from a large...
April 19, 2018 09:05 ET | Source: Myriad Genetics, Inc.

Myriad Announces Launch of "Go Green" Sustainability Initiative In Support of Earth Day

SALT LAKE CITY, April 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced the launch of its new Go Green sustainability...
April 17, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad to Announce Fiscal Third-Quarter 2018 Financial Results on May 8, 2018

SALT LAKE CITY, April 17, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will hold its fiscal...
April 02, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Receives Pre-Market Approval for its BRACAnalysis® Diagnostic System in Japan

SALT LAKE CITY, April 02, 2018 (GLOBE NEWSWIRE) -- Myriad Genetic Laboratories, Inc., a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), announced today that the Japanese Ministry of...